LAV
5 rounds tracked since 9 February 2026.
- Rounds
- 5
- Led
- 2
- Capital in these rounds
- $404M
Sectors
Countries
Rounds
- ConvergenDevelops targeted protein degradation therapies for protein aggregation diseases $15MSeed · 31 Aug
- Syneron BioDevelops macrocyclic peptide drugs through its intelligent Synova discovery platform $150MSeries B · 3 Apr
- Excalipoint TherapeuticsClinical-stage biotechnology company developing novel therapeutics, details limited in the roundup. $68.7MSeed · 18 Mar
- QuantXLeadDevelops oral small-molecule medicines using computationally driven drug discovery platform for immune and inflammatory diseases. $85MSeries B · 10 Feb
- QuantX BiosciencesLeadDevelops life sciences technologies, based on the headline only. $85MSeries B · 9 Feb
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise